APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prescription Weight Loss Pills

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prescription Weight Loss Pills Industry Growth and Trends Forecast to 2032

22 December 2025106 pages

Choose your research edition.

Industry ResearchPrescription Weight Loss Pills Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Weight Loss Pills Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Prescription Weight Loss Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Weight Loss Pills Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Weight Loss Pills Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Prescription Weight Loss Pills market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prescription Weight Loss Pills include Teva Pharmaceutical (Actavis), Sanofi (Adlyxin), Novo Nordisk A/S, Eli Lilly and Company (TRICARE), Pfizer, AstraZeneca (BYDUREON BCise), VIVUS (Qsymia), Rhythm Pharmaceuticals (Imcivree) and Haleon Group (alli), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prescription Weight Loss Pills market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prescription Weight Loss Pills market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prescription Weight Loss Pills market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prescription Weight Loss Pills.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prescription Weight Loss Pills market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prescription Weight Loss Pills Market by Company

Teva Pharmaceutical (Actavis)

Sanofi (Adlyxin)

Novo Nordisk A/S

Eli Lilly and Company (TRICARE)

Pfizer

AstraZeneca (BYDUREON BCise)

VIVUS (Qsymia)

Rhythm Pharmaceuticals (Imcivree)

Haleon Group (alli)

Currax Pharmaceuticals (Contrave)

CHEPLAPHARM (Xenical)

Prescription Weight Loss Pills Segment by Type

Injections

Oral Tablets

Oral Capsules

Prescription Weight Loss Pills Segment by Application

Hospital

Pharmacy

Prescription Weight Loss Pills Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Weight Loss Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Weight Loss Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Weight Loss Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prescription Weight Loss Pills manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prescription Weight Loss Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injections Table 2. Major Company of Oral Tablets Table 3. Major Company of Oral Capsules Table 4. Global Prescription Weight Loss Pills Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 6. Global Prescription Weight Loss Pills Sales Market Share in Volume by Type (2021-2026) Table 7. Global Prescription Weight Loss Pills Sales by Type (2021-2026) & (US$ Million) Table 8. Global Prescription Weight Loss Pills Sales Market Share in Value by Type (2021-2026) Table 9. Global Prescription Weight Loss Pills Price by Type (2021-2026) & (US$/unit) Table 10. Global Prescription Weight Loss Pills Sales by Type (2027-2032) & (k units) Table 11. Global Prescription Weight Loss Pills Sales Market Share in Volume by Type (2027-2032) Table 12. Global Prescription Weight Loss Pills Sales by Type (2027-2032) & (US$ Million) Table 13. Global Prescription Weight Loss Pills Sales Market Share in Value by Type (2027-2032) Table 14. Global Prescription Weight Loss Pills Price by Type (2027-2032) & (US$/unit) Table 15. North America Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 16. North America Prescription Weight Loss Pills Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 18. Europe Prescription Weight Loss Pills Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Prescription Weight Loss Pills Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 22. Latin America Prescription Weight Loss Pills Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Prescription Weight Loss Pills Sales by Type (2021-2026) & (US$ Million) Table 25. Prescription Weight Loss Pills Industry Trends Table 26. Prescription Weight Loss Pills Industry Drivers Table 27. Prescription Weight Loss Pills Industry Opportunities and Challenges Table 28. Prescription Weight Loss Pills Industry Restraints Table 29. Global Prescription Weight Loss Pills Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Prescription Weight Loss Pills Revenue Market Share by Company (2021-2026) Table 31. Global Prescription Weight Loss Pills Sales by Company (2021-2026) & (k units) Table 32. Global Prescription Weight Loss Pills Sales Share by Company (2021-2026) Table 33. Global Prescription Weight Loss Pills Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Prescription Weight Loss Pills Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Prescription Weight Loss Pills Major Company Production Sites and Headquarters Table 36. Global Prescription Weight Loss Pills Company, Product Type & Application Table 37. Global Prescription Weight Loss Pills Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Prescription Weight Loss Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Prescription Weight Loss Pills Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Prescription Weight Loss Pills Sales by Region (2021-2026) & (k units) Table 42. Global Prescription Weight Loss Pills Sales Market Share in Volume by Region (2021-2026) Table 43. Global Prescription Weight Loss Pills Sales by Region (2021-2026) & (US$ Million) Table 44. Global Prescription Weight Loss Pills Sales Market Share in Value by Region (2021-2026) Table 45. Global Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Prescription Weight Loss Pills Sales by Region (2027-2032) & (k units) Table 47. Global Prescription Weight Loss Pills Sales Market Share in Volume by Region (2027-2032) Table 48. Global Prescription Weight Loss Pills Sales by Region (2027-2032) & (US$ Million) Table 49. Global Prescription Weight Loss Pills Sales Market Share in Value by Region (2027-2032) Table 50. Global Prescription Weight Loss Pills Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Prescription Weight Loss Pills Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 53. Global Prescription Weight Loss Pills Sales Market Share in Volume by Application (2021-2026) Table 54. Global Prescription Weight Loss Pills Sales by Application (2021-2026) & (US$ Million) Table 55. Global Prescription Weight Loss Pills Sales Market Share in Value by Application (2021-2026) Table 56. Global Prescription Weight Loss Pills Price by Application (2021-2026) & (US$/unit) Table 57. Global Prescription Weight Loss Pills Sales by Application (2027-2032) & (k units) Table 58. Global Prescription Weight Loss Pills Sales Market Share in Volume by Application (2027-2032) Table 59. Global Prescription Weight Loss Pills Sales by Application (2027-2032) & (US$ Million) Table 60. Global Prescription Weight Loss Pills Sales Market Share in Value by Application (2027-2032) Table 61. Global Prescription Weight Loss Pills Price by Application (2027-2032) & (US$/unit) Table 62. North America Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 63. North America Prescription Weight Loss Pills Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 65. Europe Prescription Weight Loss Pills Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Prescription Weight Loss Pills Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 69. Latin America Prescription Weight Loss Pills Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Prescription Weight Loss Pills Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Pharmaceutical (Actavis) Company Information Table 73. Teva Pharmaceutical (Actavis) Business Overview Table 74. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio Table 76. Teva Pharmaceutical (Actavis) Recent Development Table 77. Sanofi (Adlyxin) Company Information Table 78. Sanofi (Adlyxin) Business Overview Table 79. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio Table 81. Sanofi (Adlyxin) Recent Development Table 82. Novo Nordisk A/S Company Information Table 83. Novo Nordisk A/S Business Overview Table 84. Novo Nordisk A/S Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio Table 86. Novo Nordisk A/S Recent Development Table 87. Eli Lilly and Company (TRICARE) Company Information Table 88. Eli Lilly and Company (TRICARE) Business Overview Table 89. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio Table 91. Eli Lilly and Company (TRICARE) Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Pfizer Prescription Weight Loss Pills Product Portfolio Table 96. Pfizer Recent Development Table 97. AstraZeneca (BYDUREON BCise) Company Information Table 98. AstraZeneca (BYDUREON BCise) Business Overview Table 99. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio Table 101. AstraZeneca (BYDUREON BCise) Recent Development Table 102. VIVUS (Qsymia) Company Information Table 103. VIVUS (Qsymia) Business Overview Table 104. VIVUS (Qsymia) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio Table 106. VIVUS (Qsymia) Recent Development Table 107. Rhythm Pharmaceuticals (Imcivree) Company Information Table 108. Rhythm Pharmaceuticals (Imcivree) Business Overview Table 109. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio Table 111. Rhythm Pharmaceuticals (Imcivree) Recent Development Table 112. Haleon Group (alli) Company Information Table 113. Haleon Group (alli) Business Overview Table 114. Haleon Group (alli) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio Table 116. Haleon Group (alli) Recent Development Table 117. Currax Pharmaceuticals (Contrave) Company Information Table 118. Currax Pharmaceuticals (Contrave) Business Overview Table 119. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio Table 121. Currax Pharmaceuticals (Contrave) Recent Development Table 122. CHEPLAPHARM (Xenical) Company Information Table 123. CHEPLAPHARM (Xenical) Business Overview Table 124. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio Table 126. CHEPLAPHARM (Xenical) Recent Development Table 127. North America Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. North America Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 129. North America Prescription Weight Loss Pills Sales Market Share by Country (2021-2026) Table 130. North America Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (k units) Table 131. North America Prescription Weight Loss Pills Sales Market Share Forecast by Country (2027-2032) Table 132. North America Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Prescription Weight Loss Pills Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Prescription Weight Loss Pills Market Share by Country (2021-2026) Table 135. North America Prescription Weight Loss Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Prescription Weight Loss Pills Market Share Forecast by Country (2027-2032) Table 137. Europe Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Europe Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 139. Europe Prescription Weight Loss Pills Sales Market Share by Country (2021-2026) Table 140. Europe Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (k units) Table 141. Europe Prescription Weight Loss Pills Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Prescription Weight Loss Pills Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Prescription Weight Loss Pills Market Share by Country (2021-2026) Table 145. Europe Prescription Weight Loss Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Prescription Weight Loss Pills Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 149. Asia-Pacific Prescription Weight Loss Pills Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (k units) Table 151. Asia-Pacific Prescription Weight Loss Pills Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Prescription Weight Loss Pills Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Prescription Weight Loss Pills Market Share by Country (2021-2026) Table 155. Asia-Pacific Prescription Weight Loss Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Prescription Weight Loss Pills Market Share Forecast by Country (2027-2032) Table 157. Latin America Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Latin America Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 159. Latin America Prescription Weight Loss Pills Sales Market Share by Country (2021-2026) Table 160. Latin America Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (k units) Table 161. Latin America Prescription Weight Loss Pills Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Prescription Weight Loss Pills Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Prescription Weight Loss Pills Market Share by Country (2021-2026) Table 165. Latin America Prescription Weight Loss Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Prescription Weight Loss Pills Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 169. Middle East and Africa Prescription Weight Loss Pills Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Prescription Weight Loss Pills Sales Forecast by Country (2027-2032) & (k units) Table 171. Middle East and Africa Prescription Weight Loss Pills Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Prescription Weight Loss Pills Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Prescription Weight Loss Pills Market Share by Country (2021-2026) Table 175. Middle East and Africa Prescription Weight Loss Pills Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Prescription Weight Loss Pills Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Prescription Weight Loss Pills Distributors List Table 180. Prescription Weight Loss Pills Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Prescription Weight Loss Pills Image Figure 2. Global Prescription Weight Loss Pills Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Weight Loss Pills Market Size (2021-2032) & (US$ Million) Figure 4. Global Prescription Weight Loss Pills Sales (2021-2032) & (k units) Figure 5. Injections Image Figure 6. Global Injections Sales YoY Growth (2021-2032) & (k units) Figure 7. Oral Tablets Image Figure 8. Global Oral Tablets Sales YoY Growth (2021-2032) & (k units) Figure 9. Oral Capsules Image Figure 10. Global Oral Capsules Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Prescription Weight Loss Pills Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Prescription Weight Loss Pills Market Share by Type 2025 VS 2032 Figure 13. North America Prescription Weight Loss Pills Sales Market Share in Volume by Type in 2025 Figure 14. North America Prescription Weight Loss Pills Sales Market Share in Value by Type in 2025 Figure 15. Europe Prescription Weight Loss Pills Sales Market Share in Volume by Type in 2025 Figure 16. Europe Prescription Weight Loss Pills Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Prescription Weight Loss Pills Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Prescription Weight Loss Pills Sales Market Share in Value by Type in 2025 Figure 19. Latin America Prescription Weight Loss Pills Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Prescription Weight Loss Pills Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Prescription Weight Loss Pills Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Prescription Weight Loss Pills Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Prescription Weight Loss Pills Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Prescription Weight Loss Pills Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Prescription Weight Loss Pills Market Share by Application 2025 VS 2032 Figure 31. North America Prescription Weight Loss Pills Sales Market Share in Volume by Application in 2025 Figure 32. North America Prescription Weight Loss Pills Sales Market Share in Value by Application in 2025 Figure 33. Europe Prescription Weight Loss Pills Sales Market Share in Volume by Application in 2025 Figure 34. Europe Prescription Weight Loss Pills Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Prescription Weight Loss Pills Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Prescription Weight Loss Pills Sales Market Share in Value by Application in 2025 Figure 37. Latin America Prescription Weight Loss Pills Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Prescription Weight Loss Pills Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Prescription Weight Loss Pills Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Prescription Weight Loss Pills Sales Market Share in Value by Application in 2025 Figure 41. North America Prescription Weight Loss Pills Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Prescription Weight Loss Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Prescription Weight Loss Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Prescription Weight Loss Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Prescription Weight Loss Pills Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Prescription Weight Loss Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Prescription Weight Loss Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Prescription Weight Loss Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Prescription Weight Loss Pills Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Prescription Weight Loss Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Prescription Weight Loss Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Prescription Weight Loss Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Prescription Weight Loss Pills Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Prescription Weight Loss Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Prescription Weight Loss Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Prescription Weight Loss Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Prescription Weight Loss Pills Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Prescription Weight Loss Pills Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Prescription Weight Loss Pills Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Prescription Weight Loss Pills Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Prescription Weight Loss Pills Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Prescription Weight Loss Pills Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injections
  • Oral Tablets
  • Oral Capsules
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Teva Pharmaceutical (Actavis)
  • Sanofi (Adlyxin)
  • Novo Nordisk A/S
  • Eli Lilly and Company (TRICARE)
  • Pfizer
  • AstraZeneca (BYDUREON BCise)
  • VIVUS (Qsymia)
  • Rhythm Pharmaceuticals (Imcivree)
  • Haleon Group (alli)
  • Currax Pharmaceuticals (Contrave)
  • CHEPLAPHARM (Xenical)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prescription Weight Loss Pills Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prescription Weight Loss Pills Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prescription Weight Loss Pills Market by Type
  6. 1.3.1 Injections
  7. 1.3.2 Oral Tablets
  8. 1.3.3 Oral Capsules
  9. 1.4 Global Prescription Weight Loss Pills Market Size by Type
  10. 1.4.1 Global Prescription Weight Loss Pills Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Prescription Weight Loss Pills Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Prescription Weight Loss Pills Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Prescription Weight Loss Pills Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Prescription Weight Loss Pills Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Prescription Weight Loss Pills Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Prescription Weight Loss Pills Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Prescription Weight Loss Pills Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prescription Weight Loss Pills Industry Trends
  2. 2.2 Prescription Weight Loss Pills Industry Drivers
  3. 2.3 Prescription Weight Loss Pills Industry Opportunities and Challenges
  4. 2.4 Prescription Weight Loss Pills Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prescription Weight Loss Pills Revenue (2021-2026)
  2. 3.2 Global Top Players by Prescription Weight Loss Pills Sales (2021-2026)
  3. 3.3 Global Top Players by Prescription Weight Loss Pills Price (2021-2026)
  4. 3.4 Global Prescription Weight Loss Pills Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prescription Weight Loss Pills Major Company Production Sites & Headquarters
  6. 3.6 Global Prescription Weight Loss Pills Company, Product Type & Application
  7. 3.7 Global Prescription Weight Loss Pills Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prescription Weight Loss Pills Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prescription Weight Loss Pills Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prescription Weight Loss Pills Tier 1, Tier 2, and Tier 3
4 Prescription Weight Loss Pills Regional Status and Outlook
  1. 4.1 Global Prescription Weight Loss Pills Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prescription Weight Loss Pills Historic Market Size by Region
  3. 4.2.1 Global Prescription Weight Loss Pills Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prescription Weight Loss Pills Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prescription Weight Loss Pills Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prescription Weight Loss Pills Forecasted Market Size by Region
  7. 4.3.1 Global Prescription Weight Loss Pills Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prescription Weight Loss Pills Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prescription Weight Loss Pills Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prescription Weight Loss Pills by Application
  1. 5.1 Prescription Weight Loss Pills Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Prescription Weight Loss Pills Market Size by Application
  5. 5.2.1 Global Prescription Weight Loss Pills Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Prescription Weight Loss Pills Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Prescription Weight Loss Pills Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Prescription Weight Loss Pills Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Prescription Weight Loss Pills Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Prescription Weight Loss Pills Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Prescription Weight Loss Pills Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Prescription Weight Loss Pills Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical (Actavis)
  2. 6.1.1 Teva Pharmaceutical (Actavis) Company Information
  3. 6.1.2 Teva Pharmaceutical (Actavis) Business Overview
  4. 6.1.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio
  6. 6.1.5 Teva Pharmaceutical (Actavis) Recent Developments
  7. 6.2 Sanofi (Adlyxin)
  8. 6.2.1 Sanofi (Adlyxin) Company Information
  9. 6.2.2 Sanofi (Adlyxin) Business Overview
  10. 6.2.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio
  12. 6.2.5 Sanofi (Adlyxin) Recent Developments
  13. 6.3 Novo Nordisk A/S
  14. 6.3.1 Novo Nordisk A/S Company Information
  15. 6.3.2 Novo Nordisk A/S Business Overview
  16. 6.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio
  18. 6.3.5 Novo Nordisk A/S Recent Developments
  19. 6.4 Eli Lilly and Company (TRICARE)
  20. 6.4.1 Eli Lilly and Company (TRICARE) Company Information
  21. 6.4.2 Eli Lilly and Company (TRICARE) Business Overview
  22. 6.4.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio
  24. 6.4.5 Eli Lilly and Company (TRICARE) Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Prescription Weight Loss Pills Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 AstraZeneca (BYDUREON BCise)
  32. 6.6.1 AstraZeneca (BYDUREON BCise) Company Information
  33. 6.6.2 AstraZeneca (BYDUREON BCise) Business Overview
  34. 6.6.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio
  36. 6.6.5 AstraZeneca (BYDUREON BCise) Recent Developments
  37. 6.7 VIVUS (Qsymia)
  38. 6.7.1 VIVUS (Qsymia) Company Information
  39. 6.7.2 VIVUS (Qsymia) Business Overview
  40. 6.7.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio
  42. 6.7.5 VIVUS (Qsymia) Recent Developments
  43. 6.8 Rhythm Pharmaceuticals (Imcivree)
  44. 6.8.1 Rhythm Pharmaceuticals (Imcivree) Company Information
  45. 6.8.2 Rhythm Pharmaceuticals (Imcivree) Business Overview
  46. 6.8.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio
  48. 6.8.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments
  49. 6.9 Haleon Group (alli)
  50. 6.9.1 Haleon Group (alli) Company Information
  51. 6.9.2 Haleon Group (alli) Business Overview
  52. 6.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio
  54. 6.9.5 Haleon Group (alli) Recent Developments
  55. 6.10 Currax Pharmaceuticals (Contrave)
  56. 6.10.1 Currax Pharmaceuticals (Contrave) Company Information
  57. 6.10.2 Currax Pharmaceuticals (Contrave) Business Overview
  58. 6.10.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio
  60. 6.10.5 Currax Pharmaceuticals (Contrave) Recent Developments
  61. 6.11 CHEPLAPHARM (Xenical)
  62. 6.11.1 CHEPLAPHARM (Xenical) Company Information
  63. 6.11.2 CHEPLAPHARM (Xenical) Business Overview
  64. 6.11.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio
  66. 6.11.5 CHEPLAPHARM (Xenical) Recent Developments
7 North America by Country
  1. 7.1 North America Prescription Weight Loss Pills Sales by Country
  2. 7.1.1 North America Prescription Weight Loss Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prescription Weight Loss Pills Sales by Country (2021-2026)
  4. 7.1.3 North America Prescription Weight Loss Pills Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prescription Weight Loss Pills Market Size by Country
  6. 7.2.1 North America Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prescription Weight Loss Pills Market Size by Country (2021-2026)
  8. 7.2.3 North America Prescription Weight Loss Pills Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prescription Weight Loss Pills Sales by Country
  2. 8.1.1 Europe Prescription Weight Loss Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prescription Weight Loss Pills Sales by Country (2021-2026)
  4. 8.1.3 Europe Prescription Weight Loss Pills Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prescription Weight Loss Pills Market Size by Country
  6. 8.2.1 Europe Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prescription Weight Loss Pills Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prescription Weight Loss Pills Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prescription Weight Loss Pills Sales by Country
  2. 9.1.1 Asia-Pacific Prescription Weight Loss Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prescription Weight Loss Pills Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prescription Weight Loss Pills Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prescription Weight Loss Pills Market Size by Country
  6. 9.2.1 Asia-Pacific Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prescription Weight Loss Pills Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prescription Weight Loss Pills Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prescription Weight Loss Pills Sales by Country
  2. 10.1.1 South America Prescription Weight Loss Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prescription Weight Loss Pills Sales by Country (2021-2026)
  4. 10.1.3 South America Prescription Weight Loss Pills Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prescription Weight Loss Pills Market Size by Country
  6. 10.2.1 South America Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prescription Weight Loss Pills Market Size by Country (2021-2026)
  8. 10.2.3 South America Prescription Weight Loss Pills Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prescription Weight Loss Pills Sales by Country
  2. 11.1.1 Middle East and Africa Prescription Weight Loss Pills Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prescription Weight Loss Pills Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prescription Weight Loss Pills Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prescription Weight Loss Pills Market Size by Country
  6. 11.2.1 Middle East and Africa Prescription Weight Loss Pills Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prescription Weight Loss Pills Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prescription Weight Loss Pills Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prescription Weight Loss Pills Value Chain Analysis
  2. 12.1.1 Prescription Weight Loss Pills Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prescription Weight Loss Pills Production Mode & Process
  7. 12.2 Prescription Weight Loss Pills Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prescription Weight Loss Pills Distributors
  10. 12.2.3 Prescription Weight Loss Pills Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst